Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference25 articles.
1. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ledermann;Ann. Oncol./ESMO,2013
2. Clinical trials in recurrent ovarian cancer;Friedlander;Int. J. Gynecol. Cancer,2011
3. Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer;Vergote;Int. J. Gynecol. Cancer,2010
4. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J. Clin. Oncol.,2014
5. Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist);Lindemann;Br. J. Cancer,2017
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study;Journal of Gynecologic Oncology;2024
2. Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1;Phytotherapy Research;2023-07-13
3. Ovarian Cancer—Insights into Platinum Resistance and Overcoming It;Medicina;2023-03-10
4. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer;PLOS ONE;2023-01-06
5. Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer;International Journal of Gynecologic Cancer;2023-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3